Back to Search
Start Over
Biotech blurring: big pharma has long looked to biotechs to help fatten pipelines, but one company has experienced the benefits of keeping things in-house. Matthew Arnold looks at how Wyeth came up with another way to conduct business
- Source :
- Medical Marketing & Media. Oct, 2007, Vol. 42 Issue 10, p40, 5 p.
- Publication Year :
- 2007
-
Abstract
- [ILLUSTRATION OMITTED] As big pharma binges on biotechs to feed anemic pipelines, at least one major player isn't getting indigestion. Wyeth has been in the biotech game for more than [...]
Details
- Language :
- English
- ISSN :
- 00257354
- Volume :
- 42
- Issue :
- 10
- Database :
- Gale General OneFile
- Journal :
- Medical Marketing & Media
- Publication Type :
- Periodical
- Accession number :
- edsgcl.170158246